Supraventricular tachycardia

Medical Clinics of North America

Volumn 85, Issue 2, 2001, Pages 193-223

  Chauhan, Vijay S ^b   Krahn, Andrew D ^b   Klein, George J ^b   Skanes, Allan C ^b   Yee, Raymond ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ATENOLOL; DIGITALIS; DIGOXIN; DILTIAZEM; DIPYRIDAMOLE; DISOPYRAMIDE; FLECAINIDE; IBUTILIDE; LIDOCAINE; METOPROLOL; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; THEOPHYLLINE; VERAPAMIL;

ALGORITHM; ARRHYTHMOGENESIS; BRADYCARDIA; CATHETER ABLATION; CLINICAL EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG INDICATION; DRUG SAFETY; DYSPNEA; ELECTROCARDIOGRAM; HEART ACCESSORY CONDUCTION PATHWAY; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REENTRY TACHYCARDIA; REVIEW; TORSADE DES POINTES;

EID: 0035113975     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70313-8     Document Type: Article

References (69)

1. Atrioventricular nodal reentry: Clinical, electrophysiological, and therapeutic considerations
2. A randomized, double-blind, placebo-controlled study of verapamil and metoprolol in treatment of multifocal atrial tachycardia
3. Clinical and electrophysiologic characteristics of patients with antidromic circus movement tachycardia in the Wolff-Parkinson-White syndrome
4. Catheter ablation of clinical intraatrial reentrant tachycardias resulting from atrial surgery, localizing and transsecting the critical isthmus
5. Electrophysiologic effects of adenosine-5′-triphosphate on atrioventricular reentrant tachycardia
6. Effects of intravenous and oral disopyramide on paroxysmal atrioventricular nodal tachycardia
7. Propafenone: A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias
8. Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients
9. Atrial fibrillation in the preexcitation syndrome
10. Recurrence and late block of accessory pathway conduction following radiofrequency catheter ablation
11. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation
12. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: A meta-analysis of randomized controlled trials
13. Tachycardie permanent par rhythm reciproque: I. Preuves du diagnostic par stimulation auriculaire et ventriculaire
14. Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia
15. Adenosine for paroxysmal supraventricular tachycardia: Dose ranging and comparison with verapamil: Assessment in placebo-controlled, multicenter trials
16. Adenosine electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia
17. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem
18. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
19. Electrophysiological effects of adenosine in the transplanted human heart: Evidence of supersensitivity
20. The preexcitation syndromes
21. The value of QRS alternation in diagnosing the site of origin of narrow QRS supraventricular tachycardia
22. The effects of adenosine on sinus node reentrant tachycardia
23. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil
24. Sustained intraatrial reentrant tachycardia: Clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up
25. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia
26. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation
27. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias
28. Magnesium and potassium therapy in multifocal atrial tachycardia
29. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction
30. Efficacy and safety of intravenous sotalol for termination of paroxysmal supraventricular tachycardia
31. Differentiation of paroxysmal narrow QRS complex tachycardias using the 12-lead electrocardiogram
32. Multifocal atrial tachycardia
33. Radiofrequency ablation for treatment of primary atrial tachycardias
34. Incidence and clinical significance of accelerated junctional rhythm following open heart surgery
35. Ventricular fibrillation in the Wolff-Parkinson-White syndrome
36. Intermittent preexcitation in the Wolff-Parkinson-White syndrome
37. Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern
38. Inappropriate sinus tachycardia: Evaluation and therapy
39. Sotalol in patients with Wolff-Parkinson-White syndrome
40. Influence of infused adenosine on bronchial tone and bronchial reactivity in asthma
41. Syncope associated with supraventricular tachycardia: An expression of tachycardia rate or vasomotor response?
42. Cardiac electrophysiology of adenosine: Basic and clinical concepts
43. Electrophysiologic effects of dipyridamole on atrioventricular nodal conduction and supraventricular tachycardia: Role of endogenous adenosine
44. Clinical safety profile of sotalol in the treatment of arrhythmias
45. Relative efficacy of various physiologic maneuvers in the termination of junctional tachycardia
46. Mechanism of "inappropriate" sinus tachycardia: Role of sympathovagal balance
47. Supraventricular tachycardia: ECG diagnosis and anatomy
48. Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan
49. Termination of focal atrial tachycardia by adenosine triphosphate
50. Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias
51. Time course of improvement in ventricular function after ablation of incessant automatic atrial tachycardia
52. Junctional tachycardia: Mechanisms, diagnosis, differential diagnosis and management
53. Mechanisms for arrhythmias
54. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentrant tachycardia
55. Electrophysiologic studies in patients with persistent atrial tachycardia
56. Digitalis in the pre-excitation syndrome: Analysis during atrial fibrillation
57. Digitalis glycosides: Mechanisms and manifestations of toxicity
58. Wide complex tachycardia: Misdiagnosis and outcome after emergent therapy
59. Mechanisms of spontaneous alternation between reciprocating tachycardia and atrial flutter-fibrillation in the Wolff-Parkinson-White syndrome
60. Intravenous verapamil for termination of reentrant supraventricular tachycardias
61. Use of P wave configuration during atrial tachycardia to predict site of origin
62. Mechanisms of cardiac arrhythmias
63. Classification and terminology of supraventricular tachycardia
64. The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex
65. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome
66. Long term therapy of paroxysmal supraventricular tachycardia: A randomized double blind comparison of digoxin, propranolol and verapamil
67. Bundle-branch block with short PR interval in healthy young people prone to paroxysmal tachycardia
68. Demonstration of sustained sinus and atrial reentry as a mechanism of paroxysmal supraventricular tachycardia
69. Effects of quinidine on atrioventricular nodal reentrant paroxysmal tachycardia